About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation (EW) has been publicly traded since 2000, making it a 26-year-old public company. It operates in the Medical Devices industry within the Healthcare sector. The company is headquartered in Irvine, United States and employs approximately 16,000 people. With a market capitalization of $48 billion, EW is a large established company.
Key Statistics
- Current Price
- $81.81
- Market Cap
- $47.52B
- 52-Week High
- $87.89
- 52-Week Low
- $65.94
- Sector
- Healthcare
- Industry
- Medical Devices
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -4.04% | $85.25 | $81.81 |
| 2025 | +15.16% | $74.03 | $85.25 |
| 2024 | -2.91% | $76.25 | $74.03 |
| 2023 | +2.20% | $74.61 | $76.25 |
| 2022 | -42.41% | $129.55 | $74.61 |
| 2021 | +42.00% | $91.23 | $129.55 |
| 2020 | +17.32% | $77.76 | $91.23 |
| 2019 | +52.31% | $51.06 | $77.76 |
| 2018 | +35.90% | $37.57 | $51.06 |
| 2017 | +20.29% | $31.23 | $37.57 |
| 2016 | +18.64% | $26.33 | $31.23 |
| 2015 | +24.01% | $21.23 | $26.33 |
| 2014 | +93.70% | $10.96 | $21.23 |
| 2013 | -27.07% | $15.03 | $10.96 |
| 2012 | +27.54% | $11.78 | $15.03 |
| 2011 | -12.54% | $13.47 | $11.78 |
| 2010 | +86.16% | $7.24 | $13.47 |
| 2009 | +58.05% | $4.58 | $7.24 |
| 2008 | +19.48% | $3.83 | $4.58 |
| 2007 | -2.23% | $3.92 | $3.83 |
| 2006 | +13.05% | $3.47 | $3.92 |
| 2005 | +0.85% | $3.44 | $3.47 |
| 2004 | +37.17% | $2.51 | $3.44 |
| 2003 | +18.10% | $2.12 | $2.51 |
| 2002 | -7.82% | $2.30 | $2.12 |
| 2001 | +55.66% | $1.48 | $2.30 |
Valuation
EW currently trades at a trailing P/E ratio of 45.2, which is considered high relative to the broader market. The forward P/E of 24.7 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 4.6. The price-to-sales ratio is 7.8.
Dividends
Edwards Lifesciences Corporation does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
EW has a beta of 0.93, indicating it is similarly volatile to the overall market. The stock's 52-week range is $65.94 to $87.89, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 28 analyst opinions, EW has a consensus "buy" rating. The average price target of $96.46 suggests 17.9% upside from current levels.
Frequently Asked Questions
What does Edwards Lifesciences Corporation do? ▼
Edwards Lifesciences Corporation is a Medical Devices company operating in the Healthcare sector. The company is headquartered in Irvine, United States.
What sector is EW in? ▼
EW operates in the Healthcare sector, specifically in the Medical Devices industry.
When did EW go public? ▼
Edwards Lifesciences Corporation went public in 2000, making it a 26-year-old public company as of 2026.
How much would $1,000 invested in EW 5 years ago be worth today? ▼
A $1,000 investment in EW five years ago would be worth approximately $997 today, representing a -0.3% return.
Does EW pay dividends? ▼
No, Edwards Lifesciences Corporation does not currently pay a dividend. The company reinvests its earnings into growth.
What is EW's market cap? ▼
Edwards Lifesciences Corporation has a market capitalization of $48 billion, classifying it as a large-cap company.
What is EW's P/E ratio? ▼
EW has a trailing P/E ratio of 45.2 and a forward P/E of 24.7, which measures how much investors are paying per dollar of earnings.
Is EW a buy, hold, or sell? ▼
Based on 28 opinions, EW has a consensus "buy" rating. The average price target is $96.46.
Last updated: 3/14/2026